📖
Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.
Lim JW, Kim H, Lee H, Kim H, Kim K, Ryu K, Chang MJ

Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Pharmaceutics.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.
Author / Organization Lim JW, Kim H, Lee H, Kim H, Kim K, Ryu K, Chang MJ
Subject & Discipline Pharmaceutics
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-148731
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »